- Analysts are undecided on whether there will be litigation if there is an ETH ETF rejection in May.
- But the odds of approval in May remain very low across the board.
As the deadline draws closer, Ethereum [ETH] ETF approval odds in May seem unlikely. However, some have been quick to imagine what would happen if the ETH ETFs faced rejection in May.
Could Grayscale, for example, sue the SEC as it did back in 2022 when the regulator rejected its application to convert GBTC to a spot Bitcoin [BTC] ETF?
Bloomberg ETF analyst Eric Balchunas thinks Grayscale will likely not pursue litigation if ETH ETFs are rejected in May. Citing the limited market share of ETH ETF futures market compared to BTC’s, the analyst said,
“A lot of people assuming Grayscale (or someone) will sue SEC after they reject the Ether spot ETFs. I would question this as Ether futures only ETFs have 4% of the assets that Bitcoin futures have.”
The analyst added,
“That’s a lot of time and money for something that may only get a fraction of the aum.”
JPMorgan expects litigation in case of ETH ETF May rejection
Balchunas’ position is contrarian to that of JPMorgan analysts. In an interview with The Block, JPMorgan maintained an optimistic view of an eventual approval for spot ETH ETFs.
JPMorgan lead analyst Nikolaos Panigirtzoglou noted that,
“If there is no spot Ethereum ETF approval in May, then we assume there is going to be a litigation process after May.”
However, executives from potential issuers like VanEck and CoinShares were pessimistic about May’s approval.
In a recent CNBC interview, VanEck CEO, Jan van Eck, compared the spot BTC ETF approval process to its ETH ETF filing and stated that “right now, pins are dropping as far as Ethereum is concerned.”
On his part, CoinShares CEO Jean-Marie Mognetti said he didn’t expect an ETH ETF approval at all this year.
However, in late March, Grayscale CLO Graig Salm remained confident of May’s approval and cautioned that the regulator’s lack of engagement shouldn’t be considered to indicate a specific outcome.
Even so, it remains to be seen whether a person or one of the potential issuers will pursue litigation if spot ETH ETF applications are rejected in May.
generic clomiphene walmart clomiphene for sale in usa how can i get cheap clomiphene tablets clomiphene order get generic clomiphene without insurance clomid rx for men buy clomid without prescription
The thoroughness in this piece is noteworthy.
This is a topic which is forthcoming to my heart… Diverse thanks! Exactly where can I lay one’s hands on the phone details an eye to questions?
azithromycin uk – buy ciplox for sale generic metronidazole 200mg
buy rybelsus 14 mg online – cyproheptadine 4 mg pills buy cyproheptadine paypal
buy motilium tablets – domperidone 10mg us purchase flexeril online cheap
amoxil over the counter – buy combivent pills order ipratropium 100 mcg sale
cost azithromycin 500mg – nebivolol 5mg oral nebivolol 20mg pill
amoxiclav price – atbioinfo ampicillin cheap
buy cheap esomeprazole – https://anexamate.com/ order esomeprazole 20mg online
warfarin for sale – https://coumamide.com/ brand cozaar
order meloxicam 15mg generic – moboxsin brand meloxicam
deltasone 10mg usa – apreplson.com brand deltasone 5mg
cheapest ed pills online – best non prescription ed pills pills erectile dysfunction
cheap amoxil tablets – purchase amoxicillin without prescription how to buy amoxicillin
purchase diflucan online cheap – cost fluconazole 200mg order diflucan sale
buy escitalopram 10mg pill – order lexapro 20mg sale lexapro 20mg cost
buy cenforce no prescription – click cost cenforce 50mg
what is the normal dose of cialis – https://ciltadgn.com/ when does cialis go off patent
canadian pharmacy cialis 20mg – https://strongtadafl.com/# cheap cialis for sale
buy generic ranitidine – this generic ranitidine 150mg